Q1 2026 EPS Estimates for Integer Holdings Co. Lifted by Zacks Research (NYSE:ITGR)

Integer Holdings Co. (NYSE:ITGR) – Stock analysts at Zacks Research upped their Q1 2026 EPS estimates for Integer in a research note issued on Monday, July 22nd. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings of $1.66 per share for the quarter, up from their prior estimate of $1.65. The consensus estimate for Integer’s current full-year earnings is $5.27 per share.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The business had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. During the same quarter last year, the business earned $0.87 EPS. The firm’s quarterly revenue was up 9.5% on a year-over-year basis.

Several other research analysts have also issued reports on the company. Benchmark reaffirmed a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Friday, May 10th. Citigroup raised their price target on shares of Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a report on Wednesday, May 22nd. KeyCorp upped their price objective on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research note on Tuesday, April 9th. Truist Financial started coverage on shares of Integer in a research note on Wednesday, May 15th. They set a “buy” rating and a $137.00 target price for the company. Finally, Oppenheimer assumed coverage on shares of Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $128.88.

Integer Price Performance

ITGR stock opened at $115.68 on Wednesday. The company has a market capitalization of $3.88 billion, a P/E ratio of 40.03, a PEG ratio of 1.86 and a beta of 1.11. The company has a fifty day moving average price of $119.11 and a 200-day moving average price of $113.04. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.01 and a current ratio of 3.32. Integer has a 52-week low of $69.40 and a 52-week high of $130.15.

Insider Buying and Selling at Integer

In related news, EVP John A. Harris sold 1,521 shares of the company’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total transaction of $183,189.24. Following the completion of the sale, the executive vice president now owns 4,922 shares in the company, valued at $592,805.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP John A. Harris sold 1,521 shares of the firm’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total transaction of $183,189.24. Following the transaction, the executive vice president now directly owns 4,922 shares of the company’s stock, valued at $592,805.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James F. Hinrichs sold 9,603 shares of the company’s stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the completion of the sale, the director now directly owns 7,424 shares of the company’s stock, valued at $908,994.56. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,936 shares of company stock worth $2,130,937. Insiders own 2.00% of the company’s stock.

Institutional Trading of Integer

A number of hedge funds have recently bought and sold shares of ITGR. Tributary Capital Management LLC grew its position in shares of Integer by 0.3% during the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after acquiring an additional 772 shares during the period. Louisiana State Employees Retirement System increased its position in Integer by 2.4% in the second quarter. Louisiana State Employees Retirement System now owns 16,900 shares of the medical equipment provider’s stock worth $1,957,000 after buying an additional 400 shares during the last quarter. Raymond James & Associates raised its stake in shares of Integer by 5.7% in the second quarter. Raymond James & Associates now owns 52,496 shares of the medical equipment provider’s stock valued at $6,079,000 after buying an additional 2,848 shares during the period. Blue Trust Inc. lifted its position in shares of Integer by 460.4% during the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock valued at $658,000 after buying an additional 4,636 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its stake in shares of Integer by 3.6% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock worth $689,000 after acquiring an additional 205 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.